Kim Hoyt

Kim Hoyt is a Principal Biostatistician at Syneos Health since July 2022, currently supporting Medical Affairs for Bristol-Myers Squibb. Previously, Kim held similar roles at Abbott and Cytel, contributing to Biogen's projects, and served as a Senior Biostatistician at Johnson & Johnson Vision from May 2013 to March 2020. Earlier experience includes a contract position at UCB Pharma, where significant contributions were made to multiple clinical trials, and a role at Alcon focused on statistical input for study design and analysis plans. Kim holds a Master of Science in Mathematics and a Bachelor of Arts in Mathematics from The University of Texas at Arlington.